Sloan Leslie Insider Trades

Insider Trading History

Track insider trading activity for Sloan Leslie. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Operating Officer
Holding Value $1.56M 130,000 shares
Last Trade
Aug 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.42M 260,000 shares
$17.00
$12.01
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Operating Officer
Holding Value $9.56M 130,000 shares
Last Trade
Aug 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$73.52
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Operating Officer
Holding Value $2.16M 180,000 shares
Last Trade
Feb 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.3M 180,000 shares
$79.25
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Operating Officer
Holding Value $1.92M 160,000 shares
Last Trade
Feb 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.4M 160,000 shares
$183.75
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Operating Officer
Holding Value $1.2M 100,000 shares
Last Trade
Feb 14, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.4M 100,000 shares
$203.75
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Mar 06, 2019 Sale
$41.7M 207,000 shares
$201.50
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Operating Officer
Holding Value $432k 36,000 shares
Last Trade
Mar 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.25M 36,000 shares
$201.50
$12.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up